Ew stock price forecast eW price forecasts remain favorable due

EW price forecasts remain favorable due to strong institutional inflows. The Chaikin money flow index is in the green, reflecting solid capital allocation into the stock. The general public, who are usually individual investors, hold a 15% stake in Edwards Lifesciences. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run. Some better-ranked stocks from the broader medical space are AngioDynamics ANGO , Veeva Systems VEEV and Masimo MASI . Technical patterns in EW show an ascending channel since early Q2, aligning with analyst forecasts that see upside toward the $96–$99 zone within two to three months, barring macroeconomic shocks.